Publication not explained
Read the Original
This page is a summary of: Emerging clinical and experimental evidence for the role of lipocalin-2 in metabolic syndrome, Clinical and Experimental Pharmacology and Physiology, January 2012, Wiley, DOI: 10.1111/j.1440-1681.2011.05557.x.
You can read the full text:
Be the first to contribute to this page